1. Home
  2. LOCO vs ATYR Comparison

LOCO vs ATYR Comparison

Compare LOCO & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo El Pollo Loco Holdings Inc.

LOCO

El Pollo Loco Holdings Inc.

HOLD

Current Price

$10.71

Market Cap

338.2M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.73

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOCO
ATYR
Founded
1980
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
338.2M
79.2M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
LOCO
ATYR
Price
$10.71
$0.73
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$15.75
$8.75
AVG Volume (30 Days)
249.1K
2.0M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
13.62
N/A
EPS
0.89
N/A
Revenue
$480,815,000.00
$190,000.00
Revenue This Year
$5.67
N/A
Revenue Next Year
$1.42
$18,728.88
P/E Ratio
$12.08
N/A
Revenue Growth
2.09
N/A
52 Week Low
$8.29
$0.64
52 Week High
$12.65
$7.29

Technical Indicators

Market Signals
Indicator
LOCO
ATYR
Relative Strength Index (RSI) 45.73 43.06
Support Level $10.46 $0.69
Resistance Level $11.74 $0.76
Average True Range (ATR) 0.26 0.04
MACD -0.13 0.01
Stochastic Oscillator 21.09 29.82

Price Performance

Historical Comparison
LOCO
ATYR

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: